BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula
LAS VEGAS, NV, Nov. 16, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTC: BDPT), a leading manufacturer and distributor of innovative, all-natural dietary supplements, highlights the importance of liver support as experts predict a steady rise of the most common form of chronic liver disease over the next 25 years.
- Scientists presenting at The Liver Meeting , held by the American Association for the Study of Liver Diseases this week, predict nearly twice as many liver cancers and almost triple the need for liver transplantation by 2050.
- Researchers also focused on increases in air pollution and the impact this will have on liver disease.
- To help support healthy liver function, BioAdaptives has announced the development of VeganHepPlusTM, a novel, all-natural, vegan supplement formula designed to promote liver detoxification and support healthy hepatic function.
- Edward Jacobs, M.D., CEO at BioAdaptives, stated, “We are very pleased to announce the development of VeganHepPlusTM, part of BioAdaptives’ strategic offering of products designed to address a wider spectrum of common health issues.